期刊文献+

阿托伐他汀钙治疗冠心病的效果及对患者血清炎症因子、氧化应激指标的影响 被引量:2

Effect of atorvastatin calcium on coronary heart disease and its influence on serum inflammatory factors and oxidative stress indexes
下载PDF
导出
摘要 目的探讨冠心病患者实施阿托伐他汀钙治疗的效果及对患者血清炎症因子、氧化应激指标的影响。方法选择本科室冠心病患者120例,根据随机数表将患者分为传统组(n=60,传统方案)与干预组(n=60,传统方案+阿托伐他汀钙),比较两组治疗效果。结果干预组患者的治疗总有效率为96.7%,高于传统组的80.0%(P<0.05),治疗后,两组患者的TFN-α、CRP、MDA水平均下降,SOD水平升高,且干预组均优于传统组(P<0.05)。结论冠心病患者实施阿托伐他汀钙治疗的疗效显著,且可改善患者血清炎症因子、氧化应激指标。 Objective To investigate the effect of atorvastatin calcium in patients with coronary heart disease and its effect on serum inflammatory factors and oxidative stress indexes. Methods A total of 120 patients with coronary heart disease in our department were selected. Patients were divided into traditional group(n=60, traditional regimen) and intervention group(n=60, traditional regimen combined with atorvastatin calcium) according to the random number table method.The efficacy of the two groups were compared. Results The total effective rate of treatment in the intervention group was96.7%, which was significantly higher than 80.0% of the traditional group(P〈0.05). After treatment, the levels of TFN-α,CRP and MDA in the two groups dicreased, and the level of SOD increased, and those in the intervention group were better than the traditional group(P〈0.05). Conclusion The atorvastatin calcium in patients with coronary heart disease has significant effect, and it can improve serum inflammatory factors and oxidative stress.
作者 钟钟 王一锦 李军农 郑燕 ZHONG Zhong;WANG Yi-jin;LI Jun-nong;ZHENG Yan(Weinan Central Hospital,Weinan 714000,China)
出处 《临床医学研究与实践》 2018年第17期26-27,共2页 Clinical Research and Practice
关键词 冠心病 阿托伐他汀钙 血清炎症因子 氧化应激指标 coronary heart disease atorvastatin calcium serum inflammatory factor oxidative stress index
  • 相关文献

参考文献8

二级参考文献77

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 2Pitt B,Loscalzo J,Monyak J,et al.Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome(from the LUNAR study)[J].Am J Cardiol,2012,109(9):1239-1246.
  • 3Xia J,Qu Y,Shen H,et al.Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload[J].Cardiology,2014,128(3):285-292.
  • 4Ong KL,Waters DD,Messig M,et al.patients with stable coronary artery disease treated with atorvastatin(from the treating to new targets study[J].Am J Cardiol,2014,113(10):1593-1598.
  • 5I Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vas- cular events in men and women with elevated C-reactive protein. N Engl J Med ,2008,359:2195-2207.
  • 6Richards AM, Januzzi JL, Troughton RW. Natriuretic peptides in heart failure with preserved ejection fraction. Heart Fail Clin, 2014,10 : 453- 470.
  • 7Berntsson J, Zia E, Borne Y, et al. Plasma natriuretic peptides and inci-dence of subtypes of isehemie stroke. Cerebrovase Dis,2014,23,37:444- 450.
  • 8林萍,任谦.红花黄色素对老年冠心病患者血脂和炎症因子影响的临床观察[J].中国医院药学杂志,2009,29(8):652-653. 被引量:28
  • 9陈焕清,熊小强,段朝晖,韩智娟,张向葵,赵凤如.复方丹参滴丸对冠心病血管内皮功能的干预及其机制[J].中山大学学报(医学科学版),2009,30(A04):221-223. 被引量:34
  • 10郑泽荣,肖波,冼志莲,骆洁恒.杏丁联合速效救心丸对急性冠脉综合征患者炎症因子的影响[J].中国中医药科技,2010,17(2):92-93. 被引量:5

共引文献137

同被引文献12

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部